Daniel Tillett
Chief Executive Officer chez RACE ONCOLOGY LIMITED
Fortune : 12 M $ au 31/03/2024
Profil
Daniel Tillett founded Nucleics Ltd., where he worked as Chief Executive Officer.
Dr. Tillett also currently works at Race Oncology Ltd., as Chief Executive Officer from 2023.
Dr. Tillett also formerly worked at Race Oncology Ltd., as Executive Director & Chief Scientific Officer from 2020 to 2023 and Simble Solutions Ltd., as Non-Executive Director from 2022 to 2023.
Dr. Tillett received his doctorate degree from the University of New South Wales Built Environment and doctorate degree from School of Biotechnology & Biomolecular Sciences.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RACE ONCOLOGY LTD.
8,16% | 25/08/2023 | 13 480 000 ( 8,16% ) | 12 M $ | 31/03/2024 |
Postes actifs de Daniel Tillett
| Sociétés | Poste | Début |
|---|---|---|
| RACE ONCOLOGY LIMITED | Chief Executive Officer | 22/11/2023 |
Anciens postes connus de Daniel Tillett
| Sociétés | Poste | Fin |
|---|---|---|
| SIMBLE SOLUTIONS LIMITED | Director/Board Member | 03/07/2023 |
| RACE ONCOLOGY LIMITED | Chief Tech/Sci/R&D Officer | 23/03/2023 |
| Nucleics Ltd. | Chief Executive Officer | - |
Formation de Daniel Tillett
| University of New South Wales Built Environment | Doctorate Degree |
| School of Biotechnology & Biomolecular Sciences | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| RACE ONCOLOGY LIMITED | Health Technology |
| SIMBLE SOLUTIONS LIMITED | Technology Services |
| Entreprise privées | 1 |
|---|---|
| Nucleics Ltd. |
